Target enrichment using selector probes. Department of Genetics and Pathology, Uppsala University



Similar documents
Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment

La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a

Ion AmpliSeq Technology

Advances in RainDance Sequence Enrichment Technology and Applications in Cancer Research. March 17, 2011 Rendez-Vous Séquençage

Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System

El papel de la anatomía patológica en oncología: presente y futuro. The role of pathological anatomy in oncology: present and future

TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING

Evaluation of a Microfluidic System for Performance of Fully Automated Companion Diagnostics for Personalized Medicine

The Power of Next-Generation Sequencing in Your Hands On the Path towards Diagnostics

Single-Cell DNA Sequencing with the C 1. Single-Cell Auto Prep System. Reveal hidden populations and genetic diversity within complex samples

Data Analysis for Ion Torrent Sequencing

Gebruik van predictieve markers voor targeted therapy in de algemene praktijk

Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests

Instruction manual for product # PNAC Version 1.2

Sahlgrenska universitetssjukhuset

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Targeted. sequencing solutions. Accurate, scalable, fast TARGETED

LeGrand Tour West Coast Adventure Race Stockholm Extreme 1-2 of May 6-7 of June of August Rank Points Class Rank Points Class Rank Points Class

White paper Evaluation of BRAF (V600E) Mutation by Immunohistochemical Staining with anti-braf V600E (VE1) Antibody: A Comparison with Sanger

WELCOME TO THE 12 TH LURN RETREAT APRIL 15 16, 2015 YSTAD SALTSJÖBAD, YSTAD

Single-Cell Whole Genome Sequencing on the C1 System: a Performance Evaluation

WHITE PAPER SEPT 2015

Accurate and sensitive mutation detection and quantitation using TaqMan Mutation Detection Assays for disease research

Core Facility Genomics

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

Nuevas tecnologías basadas en biomarcadores para oncología

PNA BRAF Mutation Detection Kit

July 7th 2009 DNA sequencing

Molecular Stratification of Cancer in the

G E N OM I C S S E RV I C ES

SEQUENCING. From Sample to Sequence-Ready

High-quality genomic DNA isolation and sensitive mutation analysis

TruSeq Custom Amplicon v1.5

Clinical Use of Molecular in the Treatment of Lung Cancer

NEIGE. diagnosis In oncogenetics. Nicolas Sévenet 02 juillet

SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications

How To Get A Cell Print

IGV Hands-on Exercise: UI basics and data integration

Big Data Part I: Data-Driven Life Sciences Innovation, Personalized Medicine and Research

STUDENT COUNCIL. Student Council spring Student Council spring Student Council autumn Student Council autumn 2011

CancerTREATMENT NGS+ NSCLC Summary Report Page 1 of 7 PATIENT SPECIMEN PHYSICIAN

20 Years Swedish Legal Integration in the EU: A Two-way Street Conference Program. February 16-17, 2015 THE SWEDISH NETWORK FOR EUROPEAN LEGAL STUDIES

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities

Diagnostics Division. Roland Diggelmann COO Roche Diagnostics. Picture

New Technologies for Sensitive, Low-Input RNA-Seq. Clontech Laboratories, Inc.

Profiling Cancer-Associated Genetic Variants on the MiniSeq System

Forensic DNA Testing Terminology

Guideline Development The American Society of Clinical Oncology

ncounter Leukemia Fusion Gene Expression Assay Molecules That Count Product Highlights ncounter Leukemia Fusion Gene Expression Assay Overview

CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE

Next generation DNA sequencing technologies. theory & prac-ce

Genetic Analysis. Phenotype analysis: biological-biochemical analysis. Genotype analysis: molecular and physical analysis

Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

Targeted Therapy What the Surgeon Needs to Know

Services. Updated 05/31/2016

Nazneen Aziz, PhD. Director, Molecular Medicine Transformation Program Office

Introduction To Real Time Quantitative PCR (qpcr)

How To Make Cancer A Clinical Sequencing

The Energy Systems Program Post graduate school and research program

MUTATION, DNA REPAIR AND CANCER

Introduction to NGS data analysis

SUPER SENSITIVE TM. mirna in FFPE. Next-Gen in situ Tissue Signature Markers Potential tool for Characterization of CUP

cansar: integrated cancer knowledgebase

Single Nucleotide Polymorphisms (SNPs)

Mitochondrial DNA Analysis

Data deluge (and it s applications) Gianluigi Zanetti. Data deluge. (and its applications) Gianluigi Zanetti

Molecular pathology of thyroid cancers

Next Generation Sequencing: Technology, Mapping, and Analysis

Independent Validation of the Prognostic Gene Expression Ratio Test in Formalin Fixed, Paraffin Embedded (FFPE) Mesothelioma Tumor Tissue Specimens

THE IMPORTANCE OF STANDARDS IN MOLECULAR-BASED ASSAYS. Liz Kerrigan Director, Standards May 8, 2014

TaqMan Mutation Detection Assay

PART 3.3: MicroRNA and Cancer

PATOLOGIA MOLECULAR DEL CANCER GINECOLOGICO. Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA.

Genetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA1 and BRCA 2)

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Overview of Next Generation Sequencing platform technologies

Breast cancer and the role of low penetrance alleles: a focus on ATM gene


Application Guide... 2

Sequencing and microarrays for genome analysis: complementary rather than competing?

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

SICKLE CELL ANEMIA & THE HEMOGLOBIN GENE TEACHER S GUIDE

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Craig Hallum Conference Investor Presentation

Next Generation Sequencing

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

Molecular analyses of EGFR: mutation and amplification detection

Test Information Sheet

Microsatellite Instability (MSI) A New Paradigm in Cancer Treatment. Lynch Syndrome OUTLINE. GI Molecular Pathology

How Sequencing Experiments Fail

Introduction to transcriptome analysis using High Throughput Sequencing technologies (HTS)

Boolean Implications Identify Wilms Tumor 1 Mutation as a Driver of DNA Hypermethylation in Acute Myeloid Leukemia

PreciseTM Whitepaper

Validation parameters: An introduction to measures of

Molekylært målrettet medicinsk kræftbehandling for klinikere principper og metoder

CCR Biology - Chapter 9 Practice Test - Summer 2012

Transcription:

Target enrichment using selector probes Mats Nilsson Department of Genetics and Pathology, Uppsala University

Target enrichment using selector probes Even with radically improved sequencing throughput, targeting will remain important when deep sequencing is required, for example: to find somatic mutations in genetically heterogeneous tumor samples and probably for diagnostics.

The selector technique Dahl, et al. (2005) Nucleic Acids Res. 33, e71, ( ), Dahl, et al. (2007) Proc. Natl. Acad. Sci. USA 104, 9387-9392 Johansson, et al., submitted

Gene panel for somaticmutationdetectionmutation AKT1 AKT2 AKT3 APC ATM BRAF CCND1 CCNE1 CDKN2A CTNNB1 EGFR FBXW7 GNAS HER2 HER3 HER4 IDH1 KRAS MET MRE11A NF1 TP53 PIK3CA PTEN SMAD2 SMAD3 SMAD4 STK11 501 exons 222 kb amplified region Bar-coded SOLiD3 sequencing

Reproducible coverage

Concordance with HapMap SNPs

Somatic mutation detection Rep1/rep2 Tumor/normal Exon1---------------------------------Exon 501

Somatic mutations

Analysis of fresh-frozen clinical lung cancer samples Tumor vs normal Detection of TP53 indel delc

Comparison cells, fresh tumor, and FFPE Cell line Fresh frozen FFPE

Sequencing 156 genes mutated in primary immuno deficiency i -1,6 Mbp target -Bar-coded Illumina sequencing FP7 Eurogenescan project: FP7 Eurogenescan project: Edvard Smith, Karolinska Institute GATC

Next generation target amplification Selector Technology Advantages Specific, virtually no off target reads (94% specificity) Low bias high coverage at low cost (98% coverage at 10x over-sequencing) Quick & Convenient Single tube/well No expensive instrumentation

Olink Genomics Reagent kit

Web page

Design report

In situ genotyping Padlock probing Target strand Rolling-circle amplification

Target-primed RCA

Detection of single nucleotide variation in the mitochondrial genome (A3243G) Larsson, C. et al. (2004) Nature Methods,1, 227-232.

Detection of single transcripts using padlock probes and RCA β actin transcripts Nuclear staining Membrane staining 30% detection efficiency Larsson, C. et al. (2010) Nature Methods,7, 395 397.

Multiplex detection of the cancer related transcripts Her2, cmyc and TERT + β-actin in different cell lines

A Detection of Her2 transcripts in Her2+ breast cancer tissue

Beta actin in FFPE tonsil tissue

In situ genotyping g of transcripts Human cell Human cell Mouse cell

In situ detection of transcripts in tissue Mouse embryonic tissue, detection of α and β actin α actins: skeletal muscle tissues β actins: most cell types as components of the cytoskeleton

Detection of a codon 12 KRAS point mutation wt wt/mut mut

Molecular Diagnostics DIGITAL RCA SELECTORS Resequencing, CNV PADLOCK In Situ The Wallenberg, Gustafsson, and Fernström foundations EURO-GENE-SCAN COMICS

MolDIa, UU Former: Dan-Oscar Antson Johan Banér Mats Gullberg Jonas Melin Fredrik Dahl Mathias Howell Johan Stenberg Anders Alderborn Present: Chatarina Larsson Sara Henriksson Ida Grundberg Jonas Jarvius Rongqin Ke Yuki Tanaka Henrik Johansson Jenny Göransson Magnus Isaksson Olle Ericsson Elin Falk Lena Spångberg Acknowledgements Collaborators at Rudbeck Ulf Landegren Ola Söderberg Rachel Nong Marie-Louise Bondeson Lotta Thuresson Fredrik Öberg Fredrik Pontén Anna Asplund Tobias Sjöblom Johan Botling Patrick Micke Marie Allen SLU/UU/Broad Inst. Leif Andersson Göran Andersson Kerstin Lindblad-Toh Ångström lab, UU Fredrik Nikolajeff Maria Strömme Peter Svedlindh Image Analysis, UU Carolina Wählby Ewert Bengtsson IMBIM, UU Dan Andersson Anna Zorzet Neuro, UU Klas Kullander Finn Hallböök Q-Linea AB Jan Grawé Anna Karman Magnus Elgh Leiden University Ton Raap Thomas Schmidt Aarhus University Jörn Koch University of Tokyo Takehiko Kitamori Nagoya University Yoshinobu Baba Harvard George Church Stanford/ParAllele/Affymetrix Paul Hardenbol et al. Karolinska Institute Nils-Göran Larsson Edvard Smith Sten Linnarsson Ali Mirazimi